Janus kinase inhibitors for the treatment of rheumatoid arthritis demonstrate similar profiles of in vitro cytokine receptor inhibition. [electronic resource]
Producer: 20200706Description: e00537 p. digitalISSN:- 2052-1707
- Antirheumatic Agents -- pharmacology
- Arthritis, Rheumatoid -- drug therapy
- Azetidines -- pharmacology
- Cell Line
- Cytokines -- metabolism
- Enzyme Assays
- Female
- Healthy Volunteers
- Heterocyclic Compounds, 3-Ring -- pharmacology
- Humans
- Inhibitory Concentration 50
- Janus Kinase 1 -- antagonists & inhibitors
- Janus Kinase Inhibitors -- pharmacology
- Male
- Piperidines -- pharmacology
- Purines
- Pyrazoles
- Pyridines -- pharmacology
- Pyrimidines -- pharmacology
- Pyrroles -- pharmacology
- Receptors, Cytokine -- antagonists & inhibitors
- Sulfonamides -- pharmacology
- Triazoles -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.